2004

Aug 16, 2004
Guidant Launches Three Innovative Heart Failure Lead Products

Advanced Leads and Lead Delivery System Further Strengthen Company''s Heart Failure Portfolio Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...

Jul 28, 2004
Guidant's Heart Failure Therapy Unanimously Recommended for a Broader Patient Population

U.S. Food and Drug Administration Advisory Committee Approval Based on Data from Company''s Landmark COMPANION Heart Failure Trial Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation...

Jul 26, 2004
Guidant Announces U.S. Launch of Next-Generation Coronary Dilatation Catheter

New Rapid-Exchange Dilatation Catheter Provides Foundation for Successful Interventional Procedures Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced the...

Jul 22, 2004
Guidant Reports Record Second Quarter Sales of $939 Million

Sales led by strong growth in worldwide implantable defibrillators Worldwide implantable defibrillator revenue of $456 million, up 21 percent Worldwide pacemaker revenue of $183 million, up 7 percent

Jul 21, 2004
Guidant Announces European Approval of Next Generation Cardiac Resynchronization Therapy Defibrillator

Innovative System Combines Treatments for Heart Failure, Atrial Arrhythmias and Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...

Show 5102550100 per page
Top